Literature DB >> 1734385

Localization of human immunodeficiency virus core antigen in term human placentas.

C F Mattern1, K Murray, A Jensen, H Farzadegan, J Pang, J F Modlin.   

Abstract

Evidence of human immunodeficiency virus (HIV) replication was sought in human placentas obtained at term from pregnancies complicated by maternal HIV infection. Placentas were obtained from the pregnancies of 19 HIV-seropositive women, 4 women who were seronegative, and 4 untested women with no risk factors for HIV infection. These placentas were each examined by immunoperoxidase immunocytochemistry using monoclonal anti-p24/55 antibodies. In addition, minced placental tissue from 11 of the seropositive pregnancies and the 3 seronegative pregnancies were co-cultivated with stimulated human peripheral blood mononuclear cells. The clinical status of the infants born to the HIV-seropositive women was assessed when the infants were 8 to 28 months of age. P24/55 antigen was detected in 5 of the 19 placentas of the HIV-seropositive pregnancies and in none of the 8 placentas of seronegative or low-risk pregnancies. This HIV core viral antigen was located exclusively in the cytoplasm of villous cells with morphological characteristics of macrophages. The HIV antigen-containing cells were very sparsely distributed. Staining of the trophoblast was not observed in any placental specimen. Human immunodeficiency virus was isolated in culture from 3 of the 11 placentas from seropositive pregnancies. Clinical follow-up has not revealed a relationship between infection of the infant and either p24/55 antigen identification or isolation of virus from the placenta. Virological and histological evidence of HIV replication is found in approximately one fourth of placentas obtained at term from pregnancies complicated by maternal HIV infection. Replicating virus appears localized to sparse macrophages located within the chorionic villi, but specifically not within the trophoblastic layer.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1734385

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  Role of the placenta in adverse perinatal outcomes among HIV-1 seropositive women.

Authors:  William Ackerman; Jesse J Kwiek
Journal:  J Nippon Med Sch       Date:  2013       Impact factor: 0.920

2.  Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV.

Authors:  E Garaci; M C Caroleo; L Aloe; S Aquaro; M Piacentini; N Costa; A Amendola; A Micera; R Caliò; C F Perno; R Levi-Montalcini
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

3.  Placental trophoblasts resist infection by multiple human immunodeficiency virus (HIV) type 1 variants even with cytomegalovirus coinfection but support HIV replication after provirus transfection.

Authors:  R T Kilani; L J Chang; M I Garcia-Lloret; D Hemmings; B Winkler-Lowen; L J Guilbert
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  The trophoblastic epithelial barrier is not infected in full-term placentae of human immunodeficiency virus-seropositive mothers undergoing antiretroviral therapy.

Authors:  C Tscherning-Casper; N Papadogiannakis; M Anvret; L Stolpe; S Lindgren; A B Bohlin; J Albert; E M Fenyö
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

5.  The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.

Authors:  S Aquaro; P Menten; S Struyf; P Proost; J Van Damme; E De Clercq; D Schols
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

6.  Adherence of human immunodeficiency virus-infected lymphocytes to fetal placental cells: a model of maternal --> fetal transmission.

Authors:  D H Schwartz; U K Sharma; E J Perlman; K Blakemore
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-14       Impact factor: 11.205

7.  Histomorphometric and immunohistochemical analysis of infectious agents, T-cell subpopulations and inflammatory adhesion molecules in placentas from HIV-seropositive pregnant women.

Authors:  Emanuele Baurakiades; Ana P C Martins; N Victor Moreschi; Camila D A Souza; Karla Abujamra; Augusto O Saito; Maíra C Mecatti; Mônica G Santos; Camilla R Pimentel; Larissa L G Silva; Cristina R Cruz; Lucia de Noronha
Journal:  Diagn Pathol       Date:  2011-10-24       Impact factor: 2.644

8.  Production of interferons and beta-chemokines by placental trophoblasts of HIV-1-infected women.

Authors:  B N Lee; H Hammill; E J Popek; S Cron; C Kozinetz; M Paul; W T Shearer; J M Reuben
Journal:  Infect Dis Obstet Gynecol       Date:  2001

Review 9.  Infections at the maternal-fetal interface: an overview of pathogenesis and defence.

Authors:  Christina J Megli; Carolyn B Coyne
Journal:  Nat Rev Microbiol       Date:  2021-08-25       Impact factor: 60.633

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.